The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Nebivolol 10mg tablets



Glenmark Arzneimittel GmbHPA22645/002/001

Main Information

Trade NameNebivolol 10mg tablets
Active SubstancesNebivolol
Dosage FormTablet
Licence HolderGlenmark Arzneimittel GmbH
Licence NumberPA22645/002/001

Group Information

ATC CodeC07AB Beta blocking agents, selective
C07AB12 nebivolol

Status

Authorised/WithdrawnAuthorised
Licence Issued17/01/2014
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back